<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">J Clin Lab Anal</journal-id>
<journal-id journal-id-type="iso-abbrev">J. Clin. Lab. Anal</journal-id>
<journal-id journal-id-type="doi">10.1002/(ISSN)1098-2825</journal-id>
<journal-id journal-id-type="publisher-id">JCLA</journal-id>
<journal-title-group>
<journal-title>Journal of Clinical Laboratory Analysis</journal-title>
</journal-title-group>
<issn pub-type="ppub">0887-8013</issn>
<issn pub-type="epub">1098-2825</issn>
<publisher>
<publisher-name>John Wiley and Sons Inc.</publisher-name>
<publisher-loc>Hoboken</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">31762079</article-id>
<article-id pub-id-type="pmc">7171339</article-id>
<article-id pub-id-type="doi">10.1002/jcla.23117</article-id>
<article-id pub-id-type="publisher-id">JCLA23117</article-id>
<article-categories>
<subj-group subj-group-type="overline">
<subject>Research Article</subject>
</subj-group>
<subj-group subj-group-type="heading">
<subject>Research Articles</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Chromosomal microarray analysis for pregnancies with or without ultrasound abnormalities in women of advanced maternal age</article-title>
<alt-title alt-title-type="left-running-head">WU et al.</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" id="jcla23117-cr-0001">
<name>
<surname>Wu</surname>
<given-names>Xiaoqing</given-names>
</name>
<contrib-id authenticated="false" contrib-id-type="orcid">https://orcid.org/0000-0003-4797-952X</contrib-id>
<xref ref-type="aff" rid="jcla23117-aff-0001">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="jcla23117-cr-0002">
<name>
<surname>An</surname>
<given-names>Gang</given-names>
</name>
<xref ref-type="aff" rid="jcla23117-aff-0001">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="jcla23117-cr-0003">
<name>
<surname>Xie</surname>
<given-names>Xiaorui</given-names>
</name>
<xref ref-type="aff" rid="jcla23117-aff-0001">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="jcla23117-cr-0004">
<name>
<surname>Su</surname>
<given-names>Linjuan</given-names>
</name>
<xref ref-type="aff" rid="jcla23117-aff-0001">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="jcla23117-cr-0005">
<name>
<surname>Cai</surname>
<given-names>Meiying</given-names>
</name>
<xref ref-type="aff" rid="jcla23117-aff-0001">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="jcla23117-cr-0006">
<name>
<surname>Chen</surname>
<given-names>Xuemei</given-names>
</name>
<xref ref-type="aff" rid="jcla23117-aff-0001">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="jcla23117-cr-0007">
<name>
<surname>Li</surname>
<given-names>Ying</given-names>
</name>
<xref ref-type="aff" rid="jcla23117-aff-0001">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="jcla23117-cr-0008">
<name>
<surname>Lin</surname>
<given-names>Na</given-names>
</name>
<xref ref-type="aff" rid="jcla23117-aff-0001">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="jcla23117-cr-0009">
<name>
<surname>He</surname>
<given-names>Deqin</given-names>
</name>
<xref ref-type="aff" rid="jcla23117-aff-0001">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="jcla23117-cr-0010">
<name>
<surname>Wang</surname>
<given-names>Meiying</given-names>
</name>
<xref ref-type="aff" rid="jcla23117-aff-0001">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="jcla23117-cr-0011">
<name>
<surname>Huang</surname>
<given-names>Hailong</given-names>
</name>
<contrib-id authenticated="false" contrib-id-type="orcid">https://orcid.org/0000-0001-5775-5082</contrib-id>
<xref ref-type="aff" rid="jcla23117-aff-0001">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author" corresp="yes" id="jcla23117-cr-0012">
<name>
<surname>Xu</surname>
<given-names>Liangpu</given-names>
</name>
<xref ref-type="aff" rid="jcla23117-aff-0001">
<sup>1</sup>
</xref>
<address>
<email>xiliangpu@fjmu.edu.cn</email>
</address>
</contrib>
</contrib-group>
<aff id="jcla23117-aff-0001">
<label><sup>1</sup></label>
<named-content content-type="organisation-division">Fujian Key Laboratory for Prenatal Diagnosis and Birth Defect</named-content>
<named-content content-type="organisation-division">Fujian Provincial Maternity and Children's Hospital</named-content>
<institution>Affiliated Hospital of Fujian Medical University</institution>
<city>Fuzhou</city>
<country country="CN">China</country>
</aff>
<author-notes>
<corresp id="correspondenceTo"><label>*</label><bold>Correspondence</bold><break></break>
Liangpu Xu, Fujian Key Laboratory for Prenatal Diagnosis and Birth Defect, Fujian Provincial Maternity and Children's Hospital, Affiliated Hospital of Fujian Medical University, No. 18 Daoshan Road, Gulou District, Fuzhou 350001, China.<break></break>
Email: <email>xiliangpu@fjmu.edu.cn</email><break></break></corresp>
</author-notes>
<pub-date pub-type="epub">
<day>24</day>
<month>11</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="collection">
<month>4</month>
<year>2020</year>
</pub-date>
<volume>34</volume>
<issue>4</issue>
<issue-id pub-id-type="doi">10.1002/jcla.v34.4</issue-id>
<elocation-id>e23117</elocation-id>
<history>
<date date-type="received">
<day>16</day>
<month>8</month>
<year>2019</year>
</date>
<date date-type="rev-recd">
<day>15</day>
<month>10</month>
<year>2019</year>
</date>
<date date-type="accepted">
<day>26</day>
<month>10</month>
<year>2019</year>
</date>
</history>
<permissions>
<!--<copyright-statement content-type="issue-copyright"> Copyright &#x000a9; 2020 Wiley Periodicals, Inc. <copyright-statement>-->
<copyright-statement content-type="article-copyright">© 2019 The Authors. <italic>Journal of Clinical Laboratory Analysis</italic> published by Wiley Periodicals, Inc.</copyright-statement>
<license license-type="creativeCommonsBy-nc">
<license-p>This is an open access article under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/4.0/">http://creativecommons.org/licenses/by-nc/4.0/</ext-link> License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.</license-p>
</license>
</permissions>
<self-uri content-type="pdf" xlink:href="file:JCLA-34-e23117.pdf"></self-uri>
<abstract id="jcla23117-abs-0001">
<title>Abstract</title>
<sec id="jcla23117-sec-0001">
<title>Background</title>
<p>Chromosomal microarray analysis (CMA) has been suggested to be routinely conducted for fetuses with ultrasound abnormalities (UA), especially with ultrasound structural anomalies (USA). Whether to routinely offer CMA to women of advanced maternal age (AMA) without UA when undergoing invasive prenatal testing is inconclusive.</p>
</sec>
<sec id="jcla23117-sec-0002">
<title>Objective</title>
<p>This study aimed to evaluate the efficiency of CMA in detecting clinically significant chromosomal abnormalities in fetuses, with or without UA, of women with AMA.</p>
</sec>
<sec id="jcla23117-sec-0003">
<title>Methods</title>
<p>Data from singleton pregnancies referred for prenatal CMA due to AMA, with or without UA were obtained. The enrolled cases were divided into AMA group (group A) and AMA accompanied by UA group (group B). Single nucleotide polymorphism (SNP) array technology and conventional karyotyping were performed simultaneously.</p>
</sec>
<sec id="jcla23117-sec-0004">
<title>Results</title>
<p>A total of 703 cases were enrolled and divided into group A (N = 437) and group B (N = 266). Clinically significant abnormalities were detected by CMA in 52 cases (7.4%, 52/703; the value in group A was significantly lower than that in group B (3.9% vs 13.2%, <italic>P</italic> &lt; .05); no statistic difference was observed with respect to submicroscopic variants of clinical significance between the two groups (0.9% vs 2.6%, <italic>P</italic> &gt; .05).</p>
</sec>
<sec id="jcla23117-sec-0005">
<title>Conclusions</title>
<p>Chromosomal microarray analysis should be available to all women with AMA undergoing invasive prenatal testing, regardless of ultrasound findings.</p>
</sec>
</abstract>
<kwd-group kwd-group-type="author-generated">
<kwd id="jcla23117-kwd-0001">advanced maternal age</kwd>
<kwd id="jcla23117-kwd-0002">chromosomal microarray analysis</kwd>
<kwd id="jcla23117-kwd-0003">conventional karyotyping</kwd>
<kwd id="jcla23117-kwd-0004">ultrasound abnormalities</kwd>
</kwd-group>
<funding-group>
<award-group id="funding-0001">
<funding-source>
<institution-wrap>
<institution>Natural Science Foundation of Fujian Province </institution>
<institution-id institution-id-type="open-funder-registry">10.13039/501100003392</institution-id>
</institution-wrap>
</funding-source>
<award-id>No. 2017J01238</award-id>
</award-group>
</funding-group>
<counts>
<fig-count count="0"></fig-count>
<table-count count="5"></table-count>
<page-count count="9"></page-count>
<word-count count="5995"></word-count>
</counts>
<custom-meta-group>
<custom-meta>
<meta-name>source-schema-version-number</meta-name>
<meta-value>2.0</meta-value>
</custom-meta>
<custom-meta>
<meta-name>cover-date</meta-name>
<meta-value>April 2020</meta-value>
</custom-meta>
<custom-meta>
<meta-name>details-of-publishers-convertor</meta-name>
<meta-value>Converter:WILEY_ML3GV2_TO_JATSPMC version:5.8.1 mode:remove_FC converted:21.04.2020</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
<notes>
<p content-type="self-citation">
<mixed-citation id="jcla23117-cit-1001" publication-type="journal">
<string-name>
<surname>Wu</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>An</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Xie</surname>
<given-names>X</given-names>
</string-name>, et al. <article-title>Chromosomal microarray analysis for pregnancies with or without ultrasound abnormalities in women of advanced maternal age</article-title>. <source xml:lang="en"/>J Clin Lab Anal. <year>2020</year>;<volume>34</volume>:<elocation-id>e23117</elocation-id>
<pub-id pub-id-type="doi">10.1002/jcla.23117</pub-id>
</mixed-citation>
</p>
<fn-group id="jcla23117-ntgp-0001">
<fn fn-type="funding" id="jcla23117-note-0001">
<p>
<bold>Funding information</bold>
</p>
<p>The present study was supported by The Fujian Provincial Natural Science Foundation (Grant No. 2017J01238).</p>
</fn>
</fn-group>
</notes>
</front>
<body id="jcla23117-body-0001">
<sec id="jcla23117-sec-0006">
<label>1</label>
<title>INTRODUCTION</title>
<p>Women with advanced maternal age (AMA) refer to pregnant women older than 35 years. The number of women with AMA has increased year by year worldwide. The proportion of women with AMA in China rose from 10.1% in 2011<xref ref-type="ref" rid="jcla23117-bib-0001">1</xref> to 20.5% in 2016.<xref ref-type="ref" rid="jcla23117-bib-0002">2</xref> For decades, AMA has been a leading indicator of invasive prenatal testing. In recent years, many pregnant women with AMA are willing to accept non‐invasive prenatal testing (NIPT) that can identify the most common fetal aneuploidies (trisomy 21, trisomy 18, and trisomy 13), and sex chromosome aneuploidies (SCAs)<xref ref-type="ref" rid="jcla23117-bib-0003">3</xref>; however, there are still a large number of women with AMA opting for invasive testing.</p>
<p>Conventional karyotyping can identify the majority of fetal chromosome abnormalities, at a resolution of greater than 10 Mb.<xref ref-type="ref" rid="jcla23117-bib-0004">4</xref> With the implementation of chromosomal microarray analysis (CMA), many chromosomal abnormalities that were undetectable by karyotyping were found in either prenatal or postnatal testing.<xref ref-type="ref" rid="jcla23117-bib-0005">5</xref>, <xref ref-type="ref" rid="jcla23117-bib-0006">6</xref>, <xref ref-type="ref" rid="jcla23117-bib-0007">7</xref> Microdeletions and microduplications have been reported in approximately 6% of pregnancies with a structural fetal abnormality and approximately 1.7% of other high‐risk pregnancies.<xref ref-type="ref" rid="jcla23117-bib-0008">8</xref>, <xref ref-type="ref" rid="jcla23117-bib-0009">9</xref> Wapner et al<xref ref-type="ref" rid="jcla23117-bib-0009">9</xref>, <xref ref-type="ref" rid="jcla23117-bib-0010">10</xref> suggest that all pregnant women, regardless of age, would equally benefit from invasive testing by fetal microarray analysis. Previous reports support CMA for all women undergoing prenatal invasive testing regardless of the presence or absence of fetal abnormality. It is well known that AMA women are at increased risk for aneuploidy due to non‐disjunction, while non‐AMA pregnancies have a higher risk for submicroscopic pathogenic aberrations than for Down syndrome.<xref ref-type="ref" rid="jcla23117-bib-0011">11</xref> Therefore, AMA women without fetal ultrasound abnormalities (UA) always express hesitation about performing CMA. Other concerns include the theoretical risk of detecting variants of unknown clinical significance (VOUS), and variants in susceptibility loci (SL),<xref ref-type="ref" rid="jcla23117-bib-0012">12</xref>, <xref ref-type="ref" rid="jcla23117-bib-0013">13</xref> as well as the higher cost of CMA compared to that of karyotyping. The purpose of this study was to evaluate the efficiency of CMA in the prenatal diagnosis of AMA women with or without UA, to provide further practical evidence for pre‐testing consultation.</p>
</sec>
<sec id="jcla23117-sec-0007" sec-type="materials-and-methods">
<label>2</label>
<title>MATERIALS AND METHODS</title>
<sec id="jcla23117-sec-0008">
<label>2.1</label>
<title>Patients and samples</title>
<p>This retrospective study reviewed 764 singleton pregnant women with AMA who underwent invasive prenatal CMA in the second or third trimester from March 2016 to October 2018. Sixty‐one women were excluded from this study for familial structural chromosome aberrations, adverse reproductive histories such as having a previous child with chromosome anomalies or dysplasia, or abnormal serological screening. As a result, 703 cases were enrolled. The mean age at delivery was 37.8 ± 2.6 years, and the mean gestational age at prenatal invasive testing was 21.4 ± 3.3 weeks. The specimens were comprised of amniotic fluid obtained during 18 and 24 gestational weeks, and fetal cord blood obtained during 25 and 35 gestational weeks (Table <xref ref-type="table" rid="jcla23117-tbl-0001">1</xref>). The resulting 703 cases enrolled were divided into the AMA group (Group A: n = 439) and the AMA accompanied by UA group (Group B: n = 266). The UA included soft markers (n = 146), ultrasound structural abnormalities (USA) (n = 84), and non‐structural anomalies (fetal growth restriction, FGR, or polyhydramnios) (n = 36). This study was approved by the local Ethics Committee of the Fujian Maternal and Child Health Hospital. Written informed consent to participate in the study was obtained from each patient.</p>
<table-wrap id="jcla23117-tbl-0001" orientation="portrait" position="float" xml:lang="en">
<label>Table 1</label>
<caption>
<p>Demographic characters for 703 women of AMA</p>
</caption>
<table frame="hsides" rules="groups">
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<thead valign="top">
<tr style="border-bottom:solid 1px #000000">
<th align="left" colspan="1" rowspan="1" valign="top"> </th>
<th align="left" colspan="1" rowspan="1" valign="top">
<p>All</p>
<p>(n = 703)</p>
</th>
<th align="left" colspan="1" rowspan="1" valign="top">
<p>Group A</p>
<p>(n = 437)</p>
</th>
<th align="left" colspan="1" rowspan="1" valign="top">
<p>Group B</p>
<p>(n = 266)</p>
</th>
<th align="left" colspan="1" rowspan="1" valign="top">
<italic>P</italic> value</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1">Age at delivery (y): mean ± SD</td>
<td align="left" colspan="1" rowspan="1">37.8 ± 2.6</td>
<td align="left" colspan="1" rowspan="1">37.5 ± 2.7</td>
<td align="left" colspan="1" rowspan="1">37.2 ± 2.4</td>
<td align="left" colspan="1" rowspan="1">&gt;.05</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Gestation age at invasive testing (wk): mean ± SD</td>
<td align="left" colspan="1" rowspan="1">21.4 ± 3.3</td>
<td align="left" colspan="1" rowspan="1">20.0 ± 1.6</td>
<td align="left" colspan="1" rowspan="1">23.8 ± 3.9</td>
<td align="left" colspan="1" rowspan="1">&lt;.05</td>
</tr>
<tr>
<td align="left" colspan="5" rowspan="1">Specimens</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="padding-left:10%">Amniotic fluid n (%)</td>
<td align="left" colspan="1" rowspan="1">623 (88.6%)</td>
<td align="left" colspan="1" rowspan="1">428 (97.9%)</td>
<td align="left" colspan="1" rowspan="1">195 (73.3%)</td>
<td align="left" colspan="1" rowspan="2">&lt;.05</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="padding-left:10%">Cord blood n (%)</td>
<td align="left" colspan="1" rowspan="1">80 (11.4%)</td>
<td align="left" colspan="1" rowspan="1">9 (2.1%)</td>
<td align="left" colspan="1" rowspan="1">71 (26.7%)</td>
</tr>
<tr>
<td align="left" colspan="5" rowspan="1">Outcomes</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="padding-left:10%">Ongoing/Live born n (%)</td>
<td align="left" colspan="1" rowspan="1">650 (92.5%)</td>
<td align="left" colspan="1" rowspan="1">422 (96.6%)</td>
<td align="left" colspan="1" rowspan="1">228 (85.7%)</td>
<td align="left" colspan="1" rowspan="2">&lt;.05</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="padding-left:10%">TOP n (%)</td>
<td align="left" colspan="1" rowspan="1">53 (7.5%)</td>
<td align="left" colspan="1" rowspan="1">15 (3.4%)</td>
<td align="left" colspan="1" rowspan="1">38 (14.3%)</td>
</tr>
</tbody>
</table>
<table-wrap-foot id="jcla23117-ntgp-0002">
<title>Note</title>
<fn id="jcla23117-note-0002">
<p>Group A: AMA without UA group; Group B: AMA accompanied with UA group.</p>
</fn>
<fn id="jcla23117-note-0003">
<p>Abbreviations: AMA, advanced maternal age; n, number of cases; TOP, termination of pregnancy; UA, ultrasound abnormality.</p>
</fn>
</table-wrap-foot>
<permissions>
<copyright-holder>John Wiley &amp; Sons, Ltd</copyright-holder>
</permissions>
</table-wrap>
</sec>
<sec id="jcla23117-sec-0009">
<label>2.2</label>
<title>CMA platforms and data interpretation</title>
<p>Genomic DNA was extracted from uncultured or cultured amniotic fluid and fetal cord blood with QIAGEN kit (Qiagen) according to its manufacturer's instructions. Chromosomal microarray analysis was performed with an Affymetrix CytoScan 750K array (Affymetrix Inc), which includes 200 000 probes for single nucleotide polymorphisms and 550 000 probes for copy number variations (CNVs) distributed across the entire human genome. To analyze the results, Chromosome Analysis Suite software (Affymetrix) and human genome version GRCh37 (hg19) were used. A resolution was generally applied: gains or losses 400 kb and loss of heterozygosity (LOH) 10 Mb. All detected CNVs were compared with in‐house and national public CNV databases as following: Database of Genomic Variants (DGV), Database of Chromosome Imbalance and Phenotype in Humans Using Ensemble Resources (DECIPHER), International Standards for Cytogenomic Arrays Consortium, and Online Mendelian Inheritance in Man (OMIM). The CNVs were classified five levels according to the American College of Medical Genetics (ACMG) definitions<xref ref-type="ref" rid="jcla23117-bib-0014">14</xref>: pathogenic, benign, likely pathogenic, likely benign, and variants of unknown significance (VOUS). All of these results were reported to patients.</p>
<p>In general, microscopically visible variants (with net imbalance ≥ 10 Mb) and submicroscopic (&lt;10 Mb) pathogenic/likely pathogenic CNVs as clinical significant findings. However, we are aware that submicroscopic chromosome abnormalities sometimes involved low‐level mosaicism with size &gt;10 Mb. Parental CMA was recommended to determine the inheritance of CNVs. In general, CNVs inherited from normal phenotype parents were regarded as likely benign, whereas de novo fetal mutations were regarded as likely pathogenic. If the CNVs have been reported to have incomplete penetrance and/or variable expressivity, we consider as likely pathogenic variants, even though it is inherited from a parent with normal phenotype.</p>
</sec>
<sec id="jcla23117-sec-0010">
<label>2.3</label>
<title>Conventional karyotyping</title>
<p>Conventional karyotyping consisted of cell culture and G‐banded karyotyping was performed according to the standard protocols in our laboratory. Cultured amniotic fluid or fetal cord blood then arrested in metaphase and finally Wright's stain was used for G‐banding at a resolution of 320‐500 bands.</p>
</sec>
<sec id="jcla23117-sec-0011">
<label>2.4</label>
<title>Statistical analysis</title>
<p>SPSS software v19.0 (SPSS Inc, Chicago, IL, US) was used for statistical analysis of the data. Statistical comparisons were performed using the independent samples <italic>t</italic> test and chi‐square test. <italic>P</italic> &lt; .05 was considered statistically significant.</p>
</sec>
</sec>
<sec id="jcla23117-sec-0012" sec-type="results">
<label>3</label>
<title>RESULTS</title>
<sec id="jcla23117-sec-0013">
<label>3.1</label>
<title>Patient clinical characteristics</title>
<p>In total, 703 cases were enrolled in the study. Demographic data are shown in Table <xref ref-type="table" rid="jcla23117-tbl-0001">1</xref>: no significant differences were found between groups A and B with respect to age at delivery; conversely, significant differences between group A and B were observed in gestational age at invasive testing, in type of specimens, and in pregnancy outcomes.</p>
</sec>
<sec id="jcla23117-sec-0014">
<label>3.2</label>
<title>CMA findings for the two groups</title>
<p>All 703 prenatal samples were processed in parallel using both CMA and conventional karyotyping. Abnormal CMA findings were detected in 60 (8.5%) fetuses. Among them, 52 (7.3%, 52/703) cases of clinically significant variants, 3 (0.4%, 3/703) cases of VOUS, 3 (0.4%, 3/703) cases of likely benign CNVs, and 2 (2.8%, 2/703) cases of LOH were identified.</p>
<p>In group A, 17 out of 437 (3.9%) cases yielded clinically significant results (Table <xref ref-type="table" rid="jcla23117-tbl-0002">2</xref>). Of those, 13 (2.9% of the cohort) were microscopic and 4 (0.9%) were submicroscopic CNVs detected by CMA only. Thirteen microscopic aberrations involved 9 (2.1%) cases of aneuploidies, 1 case of mosaic trisomy 9, whose cytogenetic karyotyping returned an additional CMA‐undetectable Roberson translocation (Case 10). As for another 3 cases (case 11‐13), cytogenetics found non‐mosaic or mosaic small supernumerary marker chromosomes (sSMC), while CMA revealed duplication in region 12p11.21q12, region 12p13.33p11.1, as well as mosaic duplication both in region 12p13.33p11.1 and 20p13p11.1, respectively. Four submicroscopic CNVs (Case 14‐17) sized from 796 kb to 10.4 Mb. Two were related to known syndrome with variable penetrance: 15q11.2 deletion syndrome (Case 15) and 16p13.11 recurrent microduplication syndrome (Case 16). Case 14 showed a de novo 3.6 Mb deletion in the 2q32.3q33.1 region, containing 12 OMIM genes. This deletion may cause stunted development, mental retardation, and characteristic facial features. Based on this result combined with the fetal cerebral ventriculomegaly found by ultrasonography at 30 weeks of gestation, the patient chose to terminate the pregnancy. Case 17 revealed a 10.4 Mb duplication in the region of 1p32.1p31.1, which maybe also related to developmental delay, mental retardation, poor language, and cognitive impairment.</p>
<table-wrap id="jcla23117-tbl-0002" orientation="portrait" position="float" xml:lang="en">
<label>Table 2</label>
<caption>
<p>List of clinical significant CMA findings for Group A</p>
</caption>
<table frame="hsides" rules="groups">
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<thead valign="top">
<tr style="border-bottom:solid 1px #000000">
<th align="left" colspan="1" rowspan="1" valign="top">Case number</th>
<th align="left" colspan="1" rowspan="1" valign="top">CMA results</th>
<th align="left" colspan="1" rowspan="1" valign="top">Copy number changes</th>
<th align="left" colspan="1" rowspan="1" valign="top">Karyotype results</th>
<th align="left" colspan="1" rowspan="1" valign="top">Parental testing</th>
<th align="left" colspan="1" rowspan="1" valign="top">Related syndrome</th>
<th align="left" colspan="1" rowspan="1" valign="top">Outcome</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="7" rowspan="1">Microscopic</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="padding-left:10%">1‐3</td>
<td align="left" colspan="1" rowspan="1">arr(21)×3</td>
<td align="left" colspan="1" rowspan="1">Dup</td>
<td align="left" colspan="1" rowspan="1">47,XX+21</td>
<td align="left" colspan="1" rowspan="1">——</td>
<td align="left" colspan="1" rowspan="1">Down's syndrome</td>
<td align="left" colspan="1" rowspan="1">TOP</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="padding-left:10%">4‐5</td>
<td align="left" colspan="1" rowspan="1">arr(21)×3</td>
<td align="left" colspan="1" rowspan="1">Dup</td>
<td align="left" colspan="1" rowspan="1">47,XY,+21</td>
<td align="left" colspan="1" rowspan="1">——</td>
<td align="left" colspan="1" rowspan="1">Down's syndrome</td>
<td align="left" colspan="1" rowspan="1">TOP</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="padding-left:10%">6</td>
<td align="left" colspan="1" rowspan="1">arr(18)×3</td>
<td align="left" colspan="1" rowspan="1">Dup</td>
<td align="left" colspan="1" rowspan="1">47,XX,+18</td>
<td align="left" colspan="1" rowspan="1">——</td>
<td align="left" colspan="1" rowspan="1">Edwards syndrome</td>
<td align="left" colspan="1" rowspan="1">TOP</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="padding-left:10%">7</td>
<td align="left" colspan="1" rowspan="1">arr(X)×2, (Y)×1</td>
<td align="left" colspan="1" rowspan="1">Dup</td>
<td align="left" colspan="1" rowspan="1">47,XXY</td>
<td align="left" colspan="1" rowspan="1">——</td>
<td align="left" colspan="1" rowspan="1">Klinefelter's syndrome</td>
<td align="left" colspan="1" rowspan="1">TOP</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="padding-left:10%">8</td>
<td align="left" colspan="1" rowspan="1">arr(X)×1, (Y)×2</td>
<td align="left" colspan="1" rowspan="1">Dup</td>
<td align="left" colspan="1" rowspan="1">47,XYY</td>
<td align="left" colspan="1" rowspan="1">——</td>
<td align="left" colspan="1" rowspan="1">Jacobs syndrome</td>
<td align="left" colspan="1" rowspan="1">TOP</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="padding-left:10%">9</td>
<td align="left" colspan="1" rowspan="1">arr(X)×1</td>
<td align="left" colspan="1" rowspan="1">Loss</td>
<td align="left" colspan="1" rowspan="1">45,X</td>
<td align="left" colspan="1" rowspan="1">——</td>
<td align="left" colspan="1" rowspan="1">Turner syndrome</td>
<td align="left" colspan="1" rowspan="1">TOP</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="padding-left:10%">10</td>
<td align="left" colspan="1" rowspan="1">arr(9)×3[0.5]</td>
<td align="left" colspan="1" rowspan="1">Mosaic dup</td>
<td align="left" colspan="1" rowspan="1">46,XY,+9,rob(13;21)(q10;q10) /45,XY,rob(13;21)(q10;q10)</td>
<td align="left" colspan="1" rowspan="1">De novo</td>
<td align="left" colspan="1" rowspan="1">
<p>Mosaic trisomy 9</p>
</td>
<td align="left" colspan="1" rowspan="1">TOP</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="padding-left:10%">11</td>
<td align="left" colspan="1" rowspan="1">arr[GRCh37] 12p11.21q12(31269113_42349971)×3</td>
<td align="left" colspan="1" rowspan="1">Dup (11 Mb)</td>
<td align="left" colspan="1" rowspan="1">47,XY,+mar</td>
<td align="left" colspan="1" rowspan="1">——</td>
<td align="left" colspan="1" rowspan="1">Non‐syndromic</td>
<td align="left" colspan="1" rowspan="1">TOP</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="padding-left:10%">12</td>
<td align="left" colspan="1" rowspan="1">arr[GRCh37] 12p13.33p11.1(173786_34835641)×3</td>
<td align="left" colspan="1" rowspan="1">Dup (34 Mb)</td>
<td align="left" colspan="1" rowspan="1">47,XX,+mar</td>
<td align="left" colspan="1" rowspan="1">——</td>
<td align="left" colspan="1" rowspan="1">Non‐syndromic</td>
<td align="left" colspan="1" rowspan="1">TOP</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="padding-left:10%">13</td>
<td align="left" colspan="1" rowspan="1">arr[GRCh37] 12p13.33p11.1(173786_34759042)×2‐3 20p13p11.1(186793_26129447)×2‐3</td>
<td align="left" colspan="1" rowspan="1">Mosaic Dup (34.5 Mb, 25.9 Mb)</td>
<td align="left" colspan="1" rowspan="1">47,XY,+mar/46,XY</td>
<td align="left" colspan="1" rowspan="1">De novo</td>
<td align="left" colspan="1" rowspan="1">Non‐syndromic</td>
<td align="left" colspan="1" rowspan="1">TOP</td>
</tr>
<tr>
<td align="left" colspan="7" rowspan="1">Submicroscopic</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="padding-left:10%">14</td>
<td align="left" colspan="1" rowspan="1">arr[GRCh37] 2q32.3q33.1(195940640_199623902)×1</td>
<td align="left" colspan="1" rowspan="1">Del (3.6 Mb)</td>
<td align="left" colspan="1" rowspan="1">46,XY</td>
<td align="left" colspan="1" rowspan="1">De novo</td>
<td align="left" colspan="1" rowspan="1">Non‐syndromic</td>
<td align="left" colspan="1" rowspan="1">TOP</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="padding-left:10%">15</td>
<td align="left" colspan="1" rowspan="1">arr[GRCh37] 15q11.2(22770421_23625785)×1</td>
<td align="left" colspan="1" rowspan="1">Del (855 kb)</td>
<td align="left" colspan="1" rowspan="1">46,XX</td>
<td align="left" colspan="1" rowspan="1">De novo</td>
<td align="left" colspan="1" rowspan="1">15q11.2 deletion syndrome</td>
<td align="left" colspan="1" rowspan="1">Live born</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="padding-left:10%">16</td>
<td align="left" colspan="1" rowspan="1">arr[GRCh37] 16p13.11(15481747_16278133)×3</td>
<td align="left" colspan="1" rowspan="1">Dup (796 kb)</td>
<td align="left" colspan="1" rowspan="1">46,XX</td>
<td align="left" colspan="1" rowspan="1">De novo</td>
<td align="left" colspan="1" rowspan="1">16p13.11 recurrent microduplication syndrome</td>
<td align="left" colspan="1" rowspan="1">Live born</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="padding-left:10%">17</td>
<td align="left" colspan="1" rowspan="1">arr[GRCh37] 1p32.1p31.1(60575608_71024736)×3</td>
<td align="left" colspan="1" rowspan="1">Dup (10.4 Mb)</td>
<td align="left" colspan="1" rowspan="1">46,XX</td>
<td align="left" colspan="1" rowspan="1">De novo</td>
<td align="left" colspan="1" rowspan="1">Non‐syndromic</td>
<td align="left" colspan="1" rowspan="1">TOP</td>
</tr>
</tbody>
</table>
<table-wrap-foot id="jcla23117-ntgp-0003">
<fn id="jcla23117-note-0004">
<p>Abbreviations: Del, deletion; Dup, duplication; TOP, termination of pregnancy.</p>
</fn>
</table-wrap-foot>
<permissions>
<copyright-holder>John Wiley &amp; Sons, Ltd</copyright-holder>
</permissions>
</table-wrap>
<p>In group B, the frequency of clinically significant findings was 13.2% (35/266) (Table <xref ref-type="table" rid="jcla23117-tbl-0003">3</xref>), which was significantly higher than that in group A (13.2% vs 3.9%, <italic>P</italic> &lt; .05). Seven cases were only detected by CMA, contributing to a detection rate of 2.6% (7/266) for clinically significant submicroscopic findings, and it showed no statistic difference from group A (2.6% vs 0.9%, <italic>P</italic> &gt; .05). These 7 cases involved 6 cases of microdeletion sized from 507 kb to 3.1 Mb and 1 case of low‐level of mosaic trisomy 22 (Case 51). Case 51 underwent amniocenteses twice during a 3‐week period; the CMA results from uncultured amniotic fluid were always mosaic trisomy 22, while the karyotypes from cultured amniotic fluid were normal. The fetus manifested with progressive fetal growth restriction (FGR), which was consistent with the phenotype of mosaic trisomy 22. The remaining 28 (10.5%) cases were karyotype detectable, including 15 cases of autosomal aneuploidy, 4 cases of sex chromosome aneuploidy, 2 cases of mosaic trisomy, 3 cases that harbored at least one duplication/deletion sized more than 10 Mb, as well as 3 cases of sSMC. In the 3 sSMCs, 2 were reported partial tetrasomy of chromosome 22q11.1 (Case 41‐42), and 1 returned a result of duplication in region 5p15.33p11 by CMA (Case 43). Trisomy 21 was the most common aneuploidy, especially in the subgroup of soft markers, trisomy 21 was the most frequent abnormalities (Table <xref ref-type="table" rid="jcla23117-tbl-0004">4</xref>). In addition to clinically significant findings, group B yielded 3 (1.1%) cases of VOUS (Table <xref ref-type="table" rid="jcla23117-tbl-0005">5</xref>), while no VOUS was detected in group A, contributing to an overall detection rate of 0.4%.</p>
<table-wrap id="jcla23117-tbl-0003" orientation="portrait" position="float" xml:lang="en">
<label>Table 3</label>
<caption>
<p>Details of the fetuses with clinical significant CMA findings in Group B</p>
</caption>
<table frame="hsides" rules="groups">
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<thead valign="top">
<tr style="border-bottom:solid 1px #000000">
<th align="left" colspan="1" rowspan="1" valign="top">Case number</th>
<th align="left" colspan="1" rowspan="1" valign="top">Ultrasound findings</th>
<th align="left" colspan="1" rowspan="1" valign="top">CMA results</th>
<th align="left" colspan="1" rowspan="1" valign="top">Karyotype results</th>
<th align="left" colspan="1" rowspan="1" valign="top">Parental testing</th>
<th align="left" colspan="1" rowspan="1" valign="top">Related syndrome</th>
<th align="left" colspan="1" rowspan="1" valign="top">Outcome</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="7" rowspan="1">Soft markers</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="padding-left:10%">18‐20</td>
<td align="left" colspan="1" rowspan="1">Nuchal translucency thickness</td>
<td align="left" colspan="1" rowspan="2">arr(21)×3</td>
<td align="left" colspan="1" rowspan="2">47,XX,+21</td>
<td align="left" colspan="1" rowspan="2">—</td>
<td align="left" colspan="1" rowspan="2">Down's syndrome</td>
<td align="left" colspan="1" rowspan="2">TOP</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="padding-left:10%">21</td>
<td align="left" colspan="1" rowspan="1">Ventricular echogenicity</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="padding-left:10%">22</td>
<td align="left" colspan="1" rowspan="1">Nuchal translucency thickness, cerebral ventriculomegaly</td>
<td align="left" colspan="1" rowspan="3">arr(21)×3</td>
<td align="left" colspan="1" rowspan="3">47,XY,+21</td>
<td align="left" colspan="1" rowspan="3">—</td>
<td align="left" colspan="1" rowspan="3">Down's syndrome</td>
<td align="left" colspan="1" rowspan="3">TOP</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="padding-left:10%">23</td>
<td align="left" colspan="1" rowspan="1">Nuchal translucency thickness, Ventricular echogenicity, Pyelic separation</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="padding-left:10%">24</td>
<td align="left" colspan="1" rowspan="1">Ventricular echogenicity, echogenic bowel, echogenic kidneys</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="padding-left:10%">25</td>
<td align="left" colspan="1" rowspan="1">Nuchal translucency thickness</td>
<td align="left" colspan="1" rowspan="2">arr(18)×3</td>
<td align="left" colspan="1" rowspan="2">47,XY,+18</td>
<td align="left" colspan="1" rowspan="2">—</td>
<td align="left" colspan="1" rowspan="2">Edwards syndrome</td>
<td align="left" colspan="1" rowspan="2">TOP</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="padding-left:10%">26</td>
<td align="left" colspan="1" rowspan="1">Choroid plexus cyst</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="padding-left:10%">27</td>
<td align="left" colspan="1" rowspan="1">Nuchal translucency thickness</td>
<td align="left" colspan="1" rowspan="1">arr(13)×3</td>
<td align="left" colspan="1" rowspan="1">47,XX,+13</td>
<td align="left" colspan="1" rowspan="1">—</td>
<td align="left" colspan="1" rowspan="1">Patau syndrome</td>
<td align="left" colspan="1" rowspan="1">TOP</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="padding-left:10%">28</td>
<td align="left" colspan="1" rowspan="1">Nuchal translucency thickness, Ventricular echogenicity, single umbilical artery</td>
<td align="left" colspan="1" rowspan="1">arr(X)×1</td>
<td align="left" colspan="1" rowspan="1">45,X</td>
<td align="left" colspan="1" rowspan="1">—</td>
<td align="left" colspan="1" rowspan="1">Turner syndrome</td>
<td align="left" colspan="1" rowspan="1">TOP</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="padding-left:10%">29</td>
<td align="left" colspan="1" rowspan="1">Nuchal translucency thickness</td>
<td align="left" colspan="1" rowspan="1">arr(X)×3</td>
<td align="left" colspan="1" rowspan="1">47,XXX</td>
<td align="left" colspan="1" rowspan="1">—</td>
<td align="left" colspan="1" rowspan="1">Trisomy X</td>
<td align="left" colspan="1" rowspan="1">TOP</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="padding-left:10%">30</td>
<td align="left" colspan="1" rowspan="1">Ventricular echogenicity, Mild tricuspid regurgitation</td>
<td align="left" colspan="1" rowspan="1">
<p>arr[GRCh37] 15q11.2(22770421_23277436)×1</p>
<p>507 kb</p>
</td>
<td align="left" colspan="1" rowspan="1">46,XX</td>
<td align="left" colspan="1" rowspan="1">Paternal</td>
<td align="left" colspan="1" rowspan="1">15q11.2 deletion syndrome</td>
<td align="left" colspan="1" rowspan="1">Live born</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="padding-left:10%">31</td>
<td align="left" colspan="1" rowspan="1">Nuchal translucency thickness</td>
<td align="left" colspan="1" rowspan="1">
<p>arr[GRCh37] 16p13.11(14910158_16508123)×1</p>
<p>1.6 Mb</p>
</td>
<td align="left" colspan="1" rowspan="1">46,XY</td>
<td align="left" colspan="1" rowspan="1">De novo</td>
<td align="left" colspan="1" rowspan="1">16p13.11 recurrent microdeletion syndrome</td>
<td align="left" colspan="1" rowspan="1">Live born</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="padding-left:10%">32</td>
<td align="left" colspan="1" rowspan="1">Nuchal translucency thickness</td>
<td align="left" colspan="1" rowspan="1">
<p>arr[GRCh37] 1q21.1q21.2(145829473_148520164) ×1</p>
<p>2.7 Mb</p>
</td>
<td align="left" colspan="1" rowspan="1">46,XX</td>
<td align="left" colspan="1" rowspan="1">De novo</td>
<td align="left" colspan="1" rowspan="1">1q21.1 microdeletion syndrome</td>
<td align="left" colspan="1" rowspan="1">TOP</td>
</tr>
<tr>
<td align="left" colspan="7" rowspan="1">Structural abnormalities</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="padding-left:10%">33‐34</td>
<td align="left" colspan="1" rowspan="1">CHD</td>
<td align="left" colspan="1" rowspan="1">arr(18)×3</td>
<td align="left" colspan="1" rowspan="1">47,XX,+18</td>
<td align="left" colspan="1" rowspan="1">—</td>
<td align="left" colspan="1" rowspan="1">Edwards syndrome</td>
<td align="left" colspan="1" rowspan="1">TOP</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="padding-left:10%">35</td>
<td align="left" colspan="1" rowspan="1">CHD, Cranial dysplasia</td>
<td align="left" colspan="1" rowspan="1">arr(18)×3</td>
<td align="left" colspan="1" rowspan="1">47,XY,+18</td>
<td align="left" colspan="1" rowspan="1">—</td>
<td align="left" colspan="1" rowspan="1">Edwards syndrome</td>
<td align="left" colspan="1" rowspan="1">TOP</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="padding-left:10%">36</td>
<td align="left" colspan="1" rowspan="1">CHD</td>
<td align="left" colspan="1" rowspan="1">arr(21)×3</td>
<td align="left" colspan="1" rowspan="1">47,XY,+21</td>
<td align="left" colspan="1" rowspan="1">—</td>
<td align="left" colspan="1" rowspan="1">Down's syndrome</td>
<td align="left" colspan="1" rowspan="1">TOP</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="padding-left:10%">37</td>
<td align="left" colspan="1" rowspan="1">CHD</td>
<td align="left" colspan="1" rowspan="1">arr(X)×1</td>
<td align="left" colspan="1" rowspan="1">45,X</td>
<td align="left" colspan="1" rowspan="1">—</td>
<td align="left" colspan="1" rowspan="1">Turner syndrome</td>
<td align="left" colspan="1" rowspan="1">TOP</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="padding-left:10%">38</td>
<td align="left" colspan="1" rowspan="1">Spinal dysplasia</td>
<td align="left" colspan="1" rowspan="1">arr(8)×3[0.7]</td>
<td align="left" colspan="1" rowspan="1">47,XY,+8/46,XY</td>
<td align="left" colspan="1" rowspan="1">—</td>
<td align="left" colspan="1" rowspan="1">Mosaic trisomy 8 syndrome</td>
<td align="left" colspan="1" rowspan="1">TOP</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="padding-left:10%">39</td>
<td align="left" colspan="1" rowspan="1">CHD</td>
<td align="left" colspan="1" rowspan="1">
<p>arr[GRCh37] 4q25q28.1(112192577_127874789)×1</p>
<p>15.6 Mb</p>
</td>
<td align="left" colspan="1" rowspan="1">46,XX,del(4)(q25q28)</td>
<td align="left" colspan="1" rowspan="1">—</td>
<td align="left" colspan="1" rowspan="1">Non‐syndromic</td>
<td align="left" colspan="1" rowspan="1">TOP</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="padding-left:10%">40</td>
<td align="left" colspan="1" rowspan="1">CHD, Cranial dysplasia</td>
<td align="left" colspan="1" rowspan="1">arr[GRCh37]13q31.3q34(94929201_115107733)×1 20.1 Mb</td>
<td align="left" colspan="1" rowspan="1">46,XX,r(13)(?p11q32)/45,XX,‐13</td>
<td align="left" colspan="1" rowspan="1">—</td>
<td align="left" colspan="1" rowspan="1">Non‐syndromic</td>
<td align="left" colspan="1" rowspan="1">TOP</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="padding-left:10%">41‐42</td>
<td align="left" colspan="1" rowspan="1">CHD</td>
<td align="left" colspan="1" rowspan="1">
<p>arr[GRCh37] 22q11.1q11.21(16888899_18649190)×4</p>
<p>1.7 Mb</p>
</td>
<td align="left" colspan="1" rowspan="1">47,XY,+mar</td>
<td align="left" colspan="1" rowspan="1">De novo</td>
<td align="left" colspan="1" rowspan="1">Non‐syndromic</td>
<td align="left" colspan="1" rowspan="1">TOP</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="padding-left:10%">43</td>
<td align="left" colspan="1" rowspan="1">CHD, Biped varus, severe pulmonary stenosis</td>
<td align="left" colspan="1" rowspan="1">arr[GRCh37] 5p15.33p11(113576_46242541)×3 46 Mb</td>
<td align="left" colspan="1" rowspan="1">47,XX,+mar</td>
<td align="left" colspan="1" rowspan="1">De novo</td>
<td align="left" colspan="1" rowspan="1">Non‐syndromic</td>
<td align="left" colspan="1" rowspan="1">TOP</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="padding-left:10%">44</td>
<td align="left" colspan="1" rowspan="1">CHD, Gallbladder enlargement</td>
<td align="left" colspan="1" rowspan="1">
<p>arr[GRCh37] 16p13.3(85880_536631)×1, 17q24.2q25.3(64966574_81041823)×3</p>
<p>451 kb, 16 Mb</p>
</td>
<td align="left" colspan="1" rowspan="1">46,XX,add(16)(p13.3)</td>
<td align="left" colspan="1" rowspan="1">De novo</td>
<td align="left" colspan="1" rowspan="1">Non‐syndromic</td>
<td align="left" colspan="1" rowspan="1">TOP</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="padding-left:10%">45‐46</td>
<td align="left" colspan="1" rowspan="1">CHD</td>
<td align="left" colspan="1" rowspan="1">
<p>arr[GRCh37] 22q11.21(18648855_21800471)×1</p>
<p>3.1 Mb</p>
</td>
<td align="left" colspan="1" rowspan="1">46,XY</td>
<td align="left" colspan="1" rowspan="1">De novo</td>
<td align="left" colspan="1" rowspan="1">DiGeorge syndrome</td>
<td align="left" colspan="1" rowspan="1">TOP</td>
</tr>
<tr>
<td align="left" colspan="7" rowspan="1">Non‐structural abnormalities</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="padding-left:10%">47</td>
<td align="left" colspan="1" rowspan="1">FGR</td>
<td align="left" colspan="1" rowspan="1">arr(21)×3</td>
<td align="left" colspan="1" rowspan="1">47,XX,+21</td>
<td align="left" colspan="1" rowspan="1">—</td>
<td align="left" colspan="1" rowspan="1">Down's syndrome</td>
<td align="left" colspan="1" rowspan="1">TOP</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="padding-left:10%">48</td>
<td align="left" colspan="1" rowspan="1">FGR</td>
<td align="left" colspan="1" rowspan="1">arr(X)×1, (Y)×2</td>
<td align="left" colspan="1" rowspan="1">47,XYY</td>
<td align="left" colspan="1" rowspan="1">—</td>
<td align="left" colspan="1" rowspan="1">Jacobs syndrome</td>
<td align="left" colspan="1" rowspan="1">TOP</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="padding-left:10%">49</td>
<td align="left" colspan="1" rowspan="1">FGR</td>
<td align="left" colspan="1" rowspan="1">
<p>arr[GRCh37] 9p24.3q13(208454_68216577)×4</p>
<p>68 Mb</p>
</td>
<td align="left" colspan="1" rowspan="1">47,XY,+psuidic(9)(q12)</td>
<td align="left" colspan="1" rowspan="1">—</td>
<td align="left" colspan="1" rowspan="1">Tetrasomy 9p syndrome</td>
<td align="left" colspan="1" rowspan="1">TOP</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="padding-left:10%">50</td>
<td align="left" colspan="1" rowspan="1">FGR</td>
<td align="left" colspan="1" rowspan="1">arr (13)×3, (20)×3[0.4]</td>
<td align="left" colspan="1" rowspan="1">48,XY,+13,+20/46,XY</td>
<td align="left" colspan="1" rowspan="1">—</td>
<td align="left" colspan="1" rowspan="1">Non‐syndromic</td>
<td align="left" colspan="1" rowspan="1">TOP</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="padding-left:10%">51</td>
<td align="left" colspan="1" rowspan="1">FGR</td>
<td align="left" colspan="1" rowspan="1">arr(22)×3[0.3]</td>
<td align="left" colspan="1" rowspan="1">46,XX</td>
<td align="left" colspan="1" rowspan="1">—</td>
<td align="left" colspan="1" rowspan="1">Mosaic trisomy‐22 syndrome</td>
<td align="left" colspan="1" rowspan="1">TOP</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="padding-left:10%">52</td>
<td align="left" colspan="1" rowspan="1">FGR</td>
<td align="left" colspan="1" rowspan="1">
<p>arr[GRCh37] 7q11.23(72713282_74154209)×1</p>
<p>1.4 Mb</p>
</td>
<td align="left" colspan="1" rowspan="1">46,XY</td>
<td align="left" colspan="1" rowspan="1">De novo</td>
<td align="left" colspan="1" rowspan="1">Williams syndrome</td>
<td align="left" colspan="1" rowspan="1">TOP</td>
</tr>
</tbody>
</table>
<table-wrap-foot id="jcla23117-ntgp-0004">
<fn id="jcla23117-note-0005">
<p>Abbreviations: CHD, congenital heart defect; FGR, fetal growth restriction; TOP, termination of pregnancy.</p>
</fn>
</table-wrap-foot>
<permissions>
<copyright-holder>John Wiley &amp; Sons, Ltd</copyright-holder>
</permissions>
</table-wrap>
<table-wrap id="jcla23117-tbl-0004" orientation="portrait" position="float" xml:lang="en">
<label>Table 4</label>
<caption>
<p>Types of CMA findings and their frequencies in 703 fetuses</p>
</caption>
<table frame="hsides" rules="groups">
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<thead valign="top">
<tr style="border-bottom:solid 1px #000000">
<th align="left" colspan="1" rowspan="2" valign="top"> </th>
<th align="left" colspan="1" rowspan="2" valign="top">
<p>Group A</p>
<p>(n = 437)</p>
</th>
<th align="left" colspan="1" rowspan="2" valign="top">
<p>Group B</p>
<p>(n = 266)</p>
</th>
<th align="left" colspan="3" rowspan="1" style="border-bottom:solid 1px #000000" valign="top">Ultrasound anomalies (n = 266)</th>
</tr>
<tr style="border-bottom:solid 1px #000000">
<th align="left" colspan="1" rowspan="1" valign="top">
<p>Soft markers</p>
<p>(n = 146)</p>
</th>
<th align="left" colspan="1" rowspan="1" valign="top">
<p>Structural anomalies</p>
<p>(n = 84)</p>
</th>
<th align="left" colspan="1" rowspan="1" valign="top">
<p>Non‐structural anomalies</p>
<p>(n = 36)</p>
</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1">Clinical significant variants</td>
<td align="left" colspan="1" rowspan="1">17 (3.9%)</td>
<td align="left" colspan="1" rowspan="1">35 (13.2%)</td>
<td align="left" colspan="1" rowspan="1">14 (9.6%)</td>
<td align="left" colspan="1" rowspan="1">15 (17.9%)</td>
<td align="left" colspan="1" rowspan="1">6 (16.7%)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Microscopic</td>
<td align="left" colspan="1" rowspan="1">13 (3.0%)</td>
<td align="left" colspan="1" rowspan="1">28 (10.5%)</td>
<td align="left" colspan="1" rowspan="1">12 (8.2%)</td>
<td align="left" colspan="1" rowspan="1">12 (14.3%)</td>
<td align="left" colspan="1" rowspan="1">4 (11.1%)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="padding-left:10%">T21</td>
<td align="left" colspan="1" rowspan="1">5 (1.1%)</td>
<td align="left" colspan="1" rowspan="1">9 (3.4%)</td>
<td align="left" colspan="1" rowspan="1">7 (4.8%)</td>
<td align="left" colspan="1" rowspan="1">1 (1.2%)</td>
<td align="left" colspan="1" rowspan="1">1 (2.8%)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="padding-left:10%">T18 and T13</td>
<td align="left" colspan="1" rowspan="1">1 (0.2%)</td>
<td align="left" colspan="1" rowspan="1">6 (2.3%)</td>
<td align="left" colspan="1" rowspan="1">3 (2.1%)</td>
<td align="left" colspan="1" rowspan="1">3 (3.6%)</td>
<td align="left" colspan="1" rowspan="1">0 (0.0%)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="padding-left:10%">SCA</td>
<td align="left" colspan="1" rowspan="1">3 (0.7%)</td>
<td align="left" colspan="1" rowspan="1">4 (1.5%)</td>
<td align="left" colspan="1" rowspan="1">2 (1.4%)</td>
<td align="left" colspan="1" rowspan="1">1 (1.2%)</td>
<td align="left" colspan="1" rowspan="1">1 (2.8%)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="padding-left:10%">Mosaicism</td>
<td align="left" colspan="1" rowspan="1">2 (0.5%)</td>
<td align="left" colspan="1" rowspan="1">2 (0.8%)</td>
<td align="left" colspan="1" rowspan="1">0 (0.0%)</td>
<td align="left" colspan="1" rowspan="1">1 (1.2%)</td>
<td align="left" colspan="1" rowspan="1">1 (2.8%)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="padding-left:10%">Deletion/duplication</td>
<td align="left" colspan="1" rowspan="1">2 (0.5%)</td>
<td align="left" colspan="1" rowspan="1">7 (2.6%)</td>
<td align="left" colspan="1" rowspan="1">0 (0.0%)</td>
<td align="left" colspan="1" rowspan="1">6 (7.1%)</td>
<td align="left" colspan="1" rowspan="1">1 (2.8%)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Submicroscopic</td>
<td align="left" colspan="1" rowspan="1">4 (0.9%)</td>
<td align="left" colspan="1" rowspan="1">7 (2.6%)</td>
<td align="left" colspan="1" rowspan="1">2 (1.4%)</td>
<td align="left" colspan="1" rowspan="1">3 (3.6%)</td>
<td align="left" colspan="1" rowspan="1">2 (5.6%)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="padding-left:10%">Microdeletion</td>
<td align="left" colspan="1" rowspan="1">2 (0.5%)</td>
<td align="left" colspan="1" rowspan="1">6 (2.3%)</td>
<td align="left" colspan="1" rowspan="1">2 (1.4%)</td>
<td align="left" colspan="1" rowspan="1">3 (3.6%)</td>
<td align="left" colspan="1" rowspan="1">1 (2.8%)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="padding-left:10%">Microduplication</td>
<td align="left" colspan="1" rowspan="1">2 (0.5%)</td>
<td align="left" colspan="1" rowspan="1">0 (0.0%)</td>
<td align="left" colspan="1" rowspan="1">0 (0.0%)</td>
<td align="left" colspan="1" rowspan="1">0 (0.0%)</td>
<td align="left" colspan="1" rowspan="1">0 (0.0%)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="padding-left:10%">Mosaicism</td>
<td align="left" colspan="1" rowspan="1">0 (0.0%)</td>
<td align="left" colspan="1" rowspan="1">1 (0.4%)</td>
<td align="left" colspan="1" rowspan="1">0 (0.0%)</td>
<td align="left" colspan="1" rowspan="1">0 (0.0%)</td>
<td align="left" colspan="1" rowspan="1">1 (2.8%)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">VOUS</td>
<td align="left" colspan="1" rowspan="1">0 (0.0%)</td>
<td align="left" colspan="1" rowspan="1">3 (1.1%)</td>
<td align="left" colspan="1" rowspan="1">1 (0.7%)</td>
<td align="left" colspan="1" rowspan="1">1 (1.2%)</td>
<td align="left" colspan="1" rowspan="1">1 (2.8%)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Likely benign CNVs</td>
<td align="left" colspan="1" rowspan="1">0 (0.0%)</td>
<td align="left" colspan="1" rowspan="1">3 (1.1%)</td>
<td align="left" colspan="1" rowspan="1">2 (1.4%)</td>
<td align="left" colspan="1" rowspan="1">1 (1.2%)</td>
<td align="left" colspan="1" rowspan="1">0 (0.0%)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Non‐CNVs</td>
<td align="left" colspan="1" rowspan="1">2 (0.5%)</td>
<td align="left" colspan="1" rowspan="1">0 (0.0%)</td>
<td align="left" colspan="1" rowspan="1">0 (0.0%)</td>
<td align="left" colspan="1" rowspan="1">0 (0.0%)</td>
<td align="left" colspan="1" rowspan="1">0 (0.0%)</td>
</tr>
</tbody>
</table>
<table-wrap-foot id="jcla23117-ntgp-0005">
<fn id="jcla23117-note-0006">
<p>Abbreviation: T13, trisomy 13; T18, trisomy 18; T21, trisomy 21; SCA, sex chromosomal aneuploidy; VOUS, variants of unknown significance.</p>
</fn>
</table-wrap-foot>
<permissions>
<copyright-holder>John Wiley &amp; Sons, Ltd</copyright-holder>
</permissions>
</table-wrap>
<table-wrap id="jcla23117-tbl-0005" orientation="portrait" position="float" xml:lang="en">
<label>Table 5</label>
<caption>
<p>Characteristics of variants without clinical significance detected by CMA</p>
</caption>
<table frame="hsides" rules="groups">
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<thead valign="top">
<tr style="border-bottom:solid 1px #000000">
<th align="left" colspan="1" rowspan="1" valign="top">Case number</th>
<th align="left" colspan="1" rowspan="1" valign="top">Indications</th>
<th align="left" colspan="1" rowspan="1" valign="top">Chromosome region</th>
<th align="left" colspan="1" rowspan="1" valign="top">Copy number changes</th>
<th align="left" colspan="1" rowspan="1" valign="top">Inheritance</th>
<th align="left" colspan="1" rowspan="1" valign="top">Significance</th>
</tr>
</thead>
<tbody>
<tr>
<td align="char" char="." colspan="1" rowspan="1">53</td>
<td align="left" colspan="1" rowspan="1">AMA, prefrontal skin thickens</td>
<td align="left" colspan="1" rowspan="1">11p11.12q11(50608808_55363330)</td>
<td align="left" colspan="1" rowspan="1">Gain (4.7 Mb)</td>
<td align="left" colspan="1" rowspan="1">De novo</td>
<td align="left" colspan="1" rowspan="1">VOUS</td>
</tr>
<tr>
<td align="char" char="." colspan="1" rowspan="1">54</td>
<td align="left" colspan="1" rowspan="1">AMA, VSD, lateral ventriculomegaly,</td>
<td align="left" colspan="1" rowspan="1">11p15.1p14.3(20745930_21780075)</td>
<td align="left" colspan="1" rowspan="1">Gain (1.0 Mb)</td>
<td align="left" colspan="1" rowspan="1">De novo</td>
<td align="left" colspan="1" rowspan="1">VOUS</td>
</tr>
<tr>
<td align="char" char="." colspan="1" rowspan="1">55</td>
<td align="left" colspan="1" rowspan="1">AMA, polyhydramnios</td>
<td align="left" colspan="1" rowspan="1">2q22.2(143043284_143866399)</td>
<td align="left" colspan="1" rowspan="1">Gain (823 kb)</td>
<td align="left" colspan="1" rowspan="1">De novo</td>
<td align="left" colspan="1" rowspan="1">VOUS</td>
</tr>
<tr>
<td align="char" char="." colspan="1" rowspan="1">56</td>
<td align="left" colspan="1" rowspan="1">AMA</td>
<td align="left" colspan="1" rowspan="1">6q14.3q21(87299268_110741585)</td>
<td align="left" colspan="1" rowspan="1">LOH (23.4 Mb)</td>
<td align="left" colspan="1" rowspan="1">De novo</td>
<td align="left" colspan="1" rowspan="1">Non‐CNVs</td>
</tr>
<tr>
<td align="char" char="." colspan="1" rowspan="1">57</td>
<td align="left" colspan="1" rowspan="1">AMA</td>
<td align="left" colspan="1" rowspan="1">3p13q13.31(71435373_116447779)</td>
<td align="left" colspan="1" rowspan="1">LOH (45.0 Mb)</td>
<td align="left" colspan="1" rowspan="1">De novo</td>
<td align="left" colspan="1" rowspan="1">Non‐CNVs</td>
</tr>
<tr>
<td align="char" char="." colspan="1" rowspan="1">58</td>
<td align="left" colspan="1" rowspan="1">AMA, lateral ventriculomegaly</td>
<td align="left" colspan="1" rowspan="1">2q13(110498141_110980295)</td>
<td align="left" colspan="1" rowspan="1">Gain (500 kb)</td>
<td align="left" colspan="1" rowspan="1">De novo</td>
<td align="left" colspan="1" rowspan="1">Likely benign</td>
</tr>
<tr>
<td align="char" char="." colspan="1" rowspan="1">59</td>
<td align="left" colspan="1" rowspan="1">AMA, lateral ventriculomegaly, echogenic bowl</td>
<td align="left" colspan="1" rowspan="1">5q33.2q33.3(154435034_156727811)</td>
<td align="left" colspan="1" rowspan="1">Gain (2.29 Mb)</td>
<td align="left" colspan="1" rowspan="1">Paternal</td>
<td align="left" colspan="1" rowspan="1">Likely benign</td>
</tr>
<tr>
<td align="char" char="." colspan="1" rowspan="1">60</td>
<td align="left" colspan="1" rowspan="1">AMA, Right ventricular wall thickened, hydropericardium</td>
<td align="left" colspan="1" rowspan="1">3p22.3(33805560_35318562)</td>
<td align="left" colspan="1" rowspan="1">Gain (1.5 Mb)</td>
<td align="left" colspan="1" rowspan="1">Maternal</td>
<td align="left" colspan="1" rowspan="1">Likely benign</td>
</tr>
</tbody>
</table>
<table-wrap-foot id="jcla23117-ntgp-0006">
<fn id="jcla23117-note-0007">
<p>Abbreviations: AMA, advanced maternal age; VSD, ventricular septal defect.</p>
</fn>
</table-wrap-foot>
<permissions>
<copyright-holder>John Wiley &amp; Sons, Ltd</copyright-holder>
</permissions>
</table-wrap>
<p>It is worth noting that CMA confirmed the nature and origin of 8 (1.1%, 8/703) cases of sSMC. Of these, four were from group A: three were clinically significant variants (Case 11‐13) and one (not listed) was normal by CMA analysis; another four cases from group B revealed three pathogenic aberrations (Case 41‐43), and one (not listed) with no change in genetic material.</p>
</sec>
</sec>
<sec id="jcla23117-sec-0015" sec-type="discussion">
<label>4</label>
<title>DISCUSSION</title>
<p>There have been various reports on the efficacy of CMA in high‐risk (mainly USA) and low‐risk populations.<xref ref-type="ref" rid="jcla23117-bib-0015">15</xref>, <xref ref-type="ref" rid="jcla23117-bib-0016">16</xref> However, in the population of AMA women, comparison between pregnancy with and without ultrasound findings was rarely reported. The purpose of this study was to investigate the necessity to perform CMA in women with AMA undergoing invasive prenatal testing.</p>
<p>We found significant differences in gestational age at diagnosis, types of specimens, and pregnancy outcomes between the two experimental groups in this study. Amniotic fluid was the predominant specimen in group A, whereas the proportion of cord blood in group B was significantly higher. This was closely related to the gestational age at the time of diagnosis. Majority of pregnant women in group A readily preferred amniocenteses because compared with choriocentesis and cordocentesis, amniocentesis is more acceptable. Accordingly, they underwent amniocentesis at the proper time. Ultrasonic structure screening is generally conducted during the 20th and 24th gestational week, and amniocentesis is generally performed before 24 weeks of gestation. Therefore, several pregnant women may be detected with fetal ultrasound problems at a later gestational age after amniotic fluid testing. This was the circumstance for case 15. The patient made the decision to terminate the pregnancy, taking into account the CMA results and subsequent ultrasound findings. This further indicates the importance of offering CMA when performing amniocentesis, that is, to avoid later cordocentesis and save time for the patient as well.</p>
<p>As expected, trisomy was the most frequent abnormal findings in this study. Chromosomal microarray analysis showed a detection rate of 0.9% for submicroscopic findings with clinical significance in the group of AMA without UA, lower compared with 1.0%‐2.1% reported in other literatures.<xref ref-type="ref" rid="jcla23117-bib-0017">17</xref>, <xref ref-type="ref" rid="jcla23117-bib-0018">18</xref>, <xref ref-type="ref" rid="jcla23117-bib-0019">19</xref>, <xref ref-type="ref" rid="jcla23117-bib-0020">20</xref> It has been reported that incremental diagnostic yield of CMA for fetuses with UA ranged from 5.2% to 10%, fetuses with ultrasound structural abnormalities ranged from 3.1% to 7.9%.<xref ref-type="ref" rid="jcla23117-bib-0016">16</xref> In our study, the value was 2.6% and 3.6%, respectively, this can be explained by the great proportion of aneuploidies caused by AMA women's basic risk for aneuploidy. The clinical significant findings in group B is more frequent than that in group A, but submicroscopic findings in the two groups showed no statistic difference. This may further imply that AMA women could be recommended for CMA testing just as UA group. Notably, clinically significant submicroscopic findings in group A were mostly associated with neurological or mental dysplasia. A susceptibility locus (SL) for neurodevelopmental disorders is considered the most common finding in pregnancies without UA.<xref ref-type="ref" rid="jcla23117-bib-0020">20</xref> They may be categorized as pathogenic/likely pathogenic findings in spite of their incomplete penetrance and variable expressivity, even inheritance from normal parents.<xref ref-type="ref" rid="jcla23117-bib-0021">21</xref>, <xref ref-type="ref" rid="jcla23117-bib-0022">22</xref>, <xref ref-type="ref" rid="jcla23117-bib-0023">23</xref> SL is generally associated with autism, learning and speech problems, mild intellectual disability (ID), or developmental delay (DD). It is well established that a second hit plays a vital role in causing an abnormal phenotype.<xref ref-type="ref" rid="jcla23117-bib-0024">24</xref> In our study, there were four cases harboring SL: 15q11.2 deletion (case 15) and 16p13.11 duplication (case 16) in group A; 15q11.2 deletion (case 30), 16p13.11 deletion (case 31) in group B. The 15q11.2 microdeletion was considered to be responsible for 15q11.2 BP1‐BP2 microdeletion syndrome. It was previously recognized as a VOUS but now is considered as likely pathogenic/pathogenic variants in many reports.<xref ref-type="ref" rid="jcla23117-bib-0025">25</xref>, <xref ref-type="ref" rid="jcla23117-bib-0026">26</xref> The penetration of the variants was estimated to be 10.4%,<xref ref-type="ref" rid="jcla23117-bib-0027">27</xref> and the prevalence in patients with mental retardation, ID, and/or multiple congenital anomalies was about two to fourfold of that in control population.<xref ref-type="ref" rid="jcla23117-bib-0027">27</xref>, <xref ref-type="ref" rid="jcla23117-bib-0028">28</xref>, <xref ref-type="ref" rid="jcla23117-bib-0029">29</xref> It is well known that being rich in low copy repeats (LCRs) increases the occurrence of non‐allelic homologous recombination resulting in duplications or deletions. This is particular for chromosome 16. Nearly 9.89% of chromosome 16 consists of LCRs. The 16p13.11 locus is a genomic hotspot encompasses a core set of eight protein‐coding genes, including NDE1, the strongest candidate gene for the neurodevelopmental phenotypes. 16p13.11 deletions are considered as pathogenic for its association with multiple phenotypic manifestations, including neurodevelopmental phenotypes such as autism, epilepsy, physical dysmorphisms, and other congenital anomalies.<xref ref-type="ref" rid="jcla23117-bib-0030">30</xref>, <xref ref-type="ref" rid="jcla23117-bib-0031">31</xref>, <xref ref-type="ref" rid="jcla23117-bib-0032">32</xref>, <xref ref-type="ref" rid="jcla23117-bib-0033">33</xref> 16p13.11 microduplication syndrome was the most commonly detected microduplication syndrome in a postnatal cohort with unexplained DD, ID, and autistic spectrum disorder (ASD)<xref ref-type="ref" rid="jcla23117-bib-0034">34</xref>; the penetration was estimated to be 10.6%. As shown in our study, fetuses with SL can be found in ultrasound normal or soft marker group, although they were live born with normal phenotype, long‐time follow‐up is crucial to assess the actual risks for neurodevelopmental disorders.<xref ref-type="ref" rid="jcla23117-bib-0035">35</xref>
</p>
<p>Chromosomal microarray analysis is of great value not only for detecting submicroscopic anomalies but also cytogenetic abnormalities with unknown origins, such as small supernumerary marker chromosomes (sSMC), whose clinical phenotype and prognosis depend on the chromosomal origin. sSMC were reported to be associated with AMA.<xref ref-type="ref" rid="jcla23117-bib-0036">36</xref> Identification of the nature and source of sSMC is the most important for pregnancy guidance. In the current study, 8 cases with de novo sSMC were diagnosed in both the groups (0.14%), 4 in each; this figure is higher than that reported previously.<xref ref-type="ref" rid="jcla23117-bib-0037">37</xref>, <xref ref-type="ref" rid="jcla23117-bib-0038">38</xref> Finally, one case in each group was confirmed by CMA as having no change in the genetic material, and the pregnancy was continued.</p>
<p>In fact, an increasing number of women has gradually accepted this relatively high‐cost test and self‐financed testing. Other barriers for consultants to offer CMA lie in interpreting the VOUS results and patient‐related concerns such as anxiety.<xref ref-type="ref" rid="jcla23117-bib-0039">39</xref> The VOUS rate detected by CMA shows considerable variability.<xref ref-type="ref" rid="jcla23117-bib-0040">40</xref>, <xref ref-type="ref" rid="jcla23117-bib-0041">41</xref> In present study, VOUS was all detected from UA group and had a relatively lower detection rate (0.4%) than other literatures, this may be explained by the limited case number. From a patient's point of view, they want to exclude as many abnormalities as possible to ensure that the fetus is healthy. Whether to choose CMA mainly depends on pre‐test counseling. As shown in this study and previous literature, while improving the detection rate of submicroscopic abnormalities in pregnancies of AMA, CMA also yields uncertain results which are unavoidable in prenatal testing for any other indications. Therefore, research should be focused on how the results should be managed, and how to provide reasonable consultation, rather than trying to avoid the uncertain results. A reasonable consultation is inseparable from the accumulation of experience, and prenatal findings combined with long‐term postnatal follow‐up are essential means to gaining experience. It is only by this method that we can provide more evidence for consultation, thus release the burdens on genetic consultants and patients.</p>
<p>In conclusion, CMA has a higher detection rate of chromosomal abnormality than conventional karyotyping, either in AMA women with or without UA. As for the population of AMA women, CMA should be available to all pregnancies undergoing invasive prenatal testing, regardless of ultrasound results.</p>
</sec>
<sec id="jcla23117-sec-0016">
<title>ETHICAL APPROVAL</title>
<p>The present study was approved by the Protection of Human Ethics Committee of Fujian Provincial Maternity and Children's Hospital, affiliated Hospital of Fujian Medical University. Written informed consent for participation was received for all patients.</p>
</sec>
</body>
<back>
<ack id="jcla23117-sec-0019">
<title>ACKNOWLEDGMENTS</title>
<p>The authors want to thank Min Zhang and Yan Wang for their technical support on SNP analysis.</p>
</ack>
<sec id="jcla23117-sec-0018" sec-type="data-availability">
<title>DATA AVAILABILITY STATEMENT</title>
<p>The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.</p>
</sec>
<ref-list content-type="cited-references" id="jcla23117-bibl-0001">
<title>REFERENCES</title>
<ref id="jcla23117-bib-0001">
<label>1</label>
<mixed-citation id="jcla23117-cit-0001" publication-type="journal">
<string-name>
<surname>Liu</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Zou</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Chen</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Ruan</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Liu</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Zhang</surname>
<given-names>W</given-names>
</string-name>. <article-title>Effects of maternal age on pregnancy: a retrospective cohort study</article-title>. <source xml:lang="en"/>Natl Med J Chin. <year>2014</year>;<volume>94</volume>(<issue>25</issue>):<fpage>1984</fpage>‐<lpage>1988</lpage>.</mixed-citation>
</ref>
<ref id="jcla23117-bib-0002">
<label>2</label>
<mixed-citation id="jcla23117-cit-0002" publication-type="journal">
<string-name>
<surname>Chen</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Zheng</surname>
<given-names>XL</given-names>
</string-name>, <string-name>
<surname>Wu</surname>
<given-names>SW</given-names>
</string-name>, <string-name>
<surname>Zhang</surname>
<given-names>WY</given-names>
</string-name>. <article-title>Clinic characteristics of women with advanced maternal age and perinatal outcomes</article-title>. <source xml:lang="en"/>Zhonghua Fu Chan Ke Za Zhi. <year>2017</year>;<volume>52</volume>;<fpage>508</fpage>‐<lpage>513</lpage>.<pub-id pub-id-type="pmid">28851166</pub-id></mixed-citation>
</ref>
<ref id="jcla23117-bib-0003">
<label>3</label>
<mixed-citation id="jcla23117-cit-0003" publication-type="journal">
<string-name>
<surname>Zhang</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Lu</surname>
<given-names>BY</given-names>
</string-name>, <string-name>
<surname>Yu</surname>
<given-names>B</given-names>
</string-name>, et al. <article-title>Noninvasive prenatal screening for fetal common sex chromosome aneuploidies from maternal blood</article-title>. <source xml:lang="en"/>J Int Med Res. <year>2017</year>;<volume>45</volume>(<issue>2</issue>):<fpage>621</fpage>‐<lpage>630</lpage>.<pub-id pub-id-type="pmid">28357876</pub-id></mixed-citation>
</ref>
<ref id="jcla23117-bib-0004">
<label>4</label>
<mixed-citation id="jcla23117-cit-0004" publication-type="journal">
<string-name>
<surname>Smeets</surname>
<given-names>DF</given-names>
</string-name>. <article-title>Historical prospective of human cytogenetics: from microscope to microarray</article-title>. <source xml:lang="en"/>Clin Biochem. <year>2004</year>;<volume>37</volume>(<issue>6</issue>):<fpage>439</fpage>‐<lpage>446</lpage>.<pub-id pub-id-type="pmid">15183291</pub-id></mixed-citation>
</ref>
<ref id="jcla23117-bib-0005">
<label>5</label>
<mixed-citation id="jcla23117-cit-0005" publication-type="journal">
<string-name>
<surname>Zhu</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Lu</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Bian</surname>
<given-names>X</given-names>
</string-name>, et al. <article-title>A multicenter study of fetal chromosomal abnormalities in Chinese women of advanced maternal age</article-title>. <source xml:lang="en"/>Taiw J Obstetr Gynecol. <year>2016</year>;<volume>55</volume>(<issue>3</issue>):<fpage>379</fpage>‐<lpage>384</lpage>.</mixed-citation>
</ref>
<ref id="jcla23117-bib-0006">
<label>6</label>
<mixed-citation id="jcla23117-cit-0006" publication-type="journal">
<string-name>
<surname>Reddy</surname>
<given-names>UM</given-names>
</string-name>, <string-name>
<surname>Page</surname>
<given-names>GP</given-names>
</string-name>, <string-name>
<surname>Saade</surname>
<given-names>GR</given-names>
</string-name>, et al. <article-title>Karyotype versus microarray testing for genetic abnormalities after stillbirth</article-title>. <source xml:lang="en"/>New Engl J Med. <year>2012</year>;<volume>367</volume>(<issue>23</issue>):<fpage>2185</fpage>‐<lpage>2193</lpage>.<pub-id pub-id-type="pmid">23215556</pub-id></mixed-citation>
</ref>
<ref id="jcla23117-bib-0007">
<label>7</label>
<mixed-citation id="jcla23117-cit-0007" publication-type="journal">
<string-name>
<surname>Shaffer</surname>
<given-names>LG</given-names>
</string-name>, <string-name>
<surname>Dabell</surname>
<given-names>MP</given-names>
</string-name>, <string-name>
<surname>Fisher</surname>
<given-names>AJ</given-names>
</string-name>, et al. <article-title>Experience with microarray‐based comparative genomic hybridization for prenatal diagnosis in over 5000 pregnancies</article-title>. <source xml:lang="en"/>Prenat Diagn. <year>2012</year>;<volume>32</volume>(<issue>10</issue>):<fpage>976</fpage>‐<lpage>985</lpage>.<pub-id pub-id-type="pmid">22865506</pub-id></mixed-citation>
</ref>
<ref id="jcla23117-bib-0008">
<label>8</label>
<mixed-citation id="jcla23117-cit-0008" publication-type="journal">
<string-name>
<surname>Ferreira</surname>
<given-names>JC</given-names>
</string-name>, <string-name>
<surname>Grati</surname>
<given-names>FR</given-names>
</string-name>, <string-name>
<surname>Bajaj</surname>
<given-names>K</given-names>
</string-name>, et al. <article-title>Frequency of fetal karyotype abnormalities in women undergoing invasive testing in the absence of ultrasound and other high‐risk indications</article-title>. <source xml:lang="en"/>Prenat Diagn. <year>2016</year>;<volume>36</volume>(<issue>12</issue>):<fpage>1146</fpage>.<pub-id pub-id-type="pmid">27770451</pub-id></mixed-citation>
</ref>
<ref id="jcla23117-bib-0009">
<label>9</label>
<mixed-citation id="jcla23117-cit-0009" publication-type="journal">
<string-name>
<surname>Fiorentino</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Napoletano</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Caiazzo</surname>
<given-names>F</given-names>
</string-name>, et al. <article-title>Chromosomal microarray analysis as a first‐line test in pregnancies with a priori low risk for the detection of submicroscopic chromosomal abnormalities</article-title>. <source xml:lang="en"/>Eur J Hum Genet. <year>2013</year>;<volume>21</volume>(<issue>7</issue>):<fpage>725</fpage>‐<lpage>730</lpage>.<pub-id pub-id-type="pmid">23211699</pub-id></mixed-citation>
</ref>
<ref id="jcla23117-bib-0010">
<label>10</label>
<mixed-citation id="jcla23117-cit-0010" publication-type="journal">
<string-name>
<surname>Hay</surname>
<given-names>SB</given-names>
</string-name>, <string-name>
<surname>Sahoo</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Travis</surname>
<given-names>MK</given-names>
</string-name>, et al. <article-title>ACOG and SMFM guidelines for prenatal diagnosis: is karyotyping really sufficient?</article-title>
<source xml:lang="en"/>Prenat Diagn. <year>2018</year>;<volume>38</volume>(<issue>3</issue>):<fpage>184</fpage>‐<lpage>189</lpage>.<pub-id pub-id-type="pmid">29315677</pub-id></mixed-citation>
</ref>
<ref id="jcla23117-bib-0011">
<label>11</label>
<mixed-citation id="jcla23117-cit-0011" publication-type="journal">
<string-name>
<surname>Srebniak</surname>
<given-names>MI</given-names>
</string-name>, <string-name>
<surname>Joosten</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Knapen</surname>
<given-names>M</given-names>
</string-name>, et al. <article-title>Frequency of submicroscopic chromosomal aberrations in pregnancies without increased risk for structural chromosomal aberrations: systematic review and meta‐analysis</article-title>. <source xml:lang="en"/>Ultrasound Obstetr Gynecol. <year>2018</year>;<volume>51</volume>(<issue>4</issue>):<fpage>445</fpage>‐<lpage>452</lpage>.</mixed-citation>
</ref>
<ref id="jcla23117-bib-0012">
<label>12</label>
<mixed-citation id="jcla23117-cit-0012" publication-type="journal">
<string-name>
<surname>Friedman</surname>
<given-names>JM</given-names>
</string-name>. <article-title>High‐resolution array genomic hybridization in prenatal diagnosis</article-title>. <source xml:lang="en"/>Prenat Diagn. <year>2009</year>;<volume>29</volume>(<issue>1</issue>):<fpage>20</fpage>‐<lpage>28</lpage>.<pub-id pub-id-type="pmid">19009552</pub-id></mixed-citation>
</ref>
<ref id="jcla23117-bib-0013">
<label>13</label>
<mixed-citation id="jcla23117-cit-0013" publication-type="journal">
<string-name>
<surname>Shuster</surname>
<given-names>E</given-names>
</string-name>. <article-title>Microarray genetic screening: a prenatal roadblock for life?</article-title>
<source xml:lang="en"/>Lancet (London, England). <year>2007</year>;<volume>369</volume>(<issue>9560</issue>):<fpage>526</fpage>‐<lpage>529</lpage>.</mixed-citation>
</ref>
<ref id="jcla23117-bib-0014">
<label>14</label>
<mixed-citation id="jcla23117-cit-0014" publication-type="journal">
<string-name>
<surname>South</surname>
<given-names>ST</given-names>
</string-name>, <string-name>
<surname>Lee</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Lamb</surname>
<given-names>AN</given-names>
</string-name>, <string-name>
<surname>Higgins</surname>
<given-names>AW</given-names>
</string-name>, <string-name>
<surname>Kearney</surname>
<given-names>HM</given-names>
</string-name>. <article-title>ACMG Standards and Guidelines for constitutional cytogenomic microarray analysis, including postnatal and prenatal applications: revision 2013</article-title>. <source xml:lang="en"/>Genet Med. <year>2013</year>;<volume>15</volume>(<issue>11</issue>):<fpage>901</fpage>‐<lpage>909</lpage>.<pub-id pub-id-type="pmid">24071793</pub-id></mixed-citation>
</ref>
<ref id="jcla23117-bib-0015">
<label>15</label>
<mixed-citation id="jcla23117-cit-0015" publication-type="journal">
<string-name>
<surname>Hillman</surname>
<given-names>SC</given-names>
</string-name>, <string-name>
<surname>McMullan</surname>
<given-names>DJ</given-names>
</string-name>, <string-name>
<surname>Hall</surname>
<given-names>G</given-names>
</string-name>, et al. <article-title>Use of prenatal chromosomal microarray: prospective cohort study and systematic review and meta‐analysis</article-title>. <source xml:lang="en"/>Ultrasound Obstetr Gynecol. <year>2013</year>;<volume>41</volume>(<issue>6</issue>):<fpage>610</fpage>‐<lpage>620</lpage>.</mixed-citation>
</ref>
<ref id="jcla23117-bib-0016">
<label>16</label>
<mixed-citation id="jcla23117-cit-0016" publication-type="journal">
<string-name>
<surname>de Wit</surname>
<given-names>MC</given-names>
</string-name>, <string-name>
<surname>Srebniak</surname>
<given-names>MI</given-names>
</string-name>, <string-name>
<surname>Govaerts</surname>
<given-names>LC</given-names>
</string-name>, <string-name>
<surname>Van Opstal</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Galjaard</surname>
<given-names>RJH</given-names>
</string-name>, <string-name>
<surname>Go</surname>
<given-names>ATJI</given-names>
</string-name>. <article-title>Additional value of prenatal genomic array testing in fetuses with isolated structural ultrasound abnormalities and a normal karyotype: a systematic review of the literature</article-title>. <source xml:lang="en"/>Ultrasound Obstetr Gynecol. <year>2014</year>;<volume>43</volume>(<issue>2</issue>):<fpage>139</fpage>‐<lpage>146</lpage>.</mixed-citation>
</ref>
<ref id="jcla23117-bib-0017">
<label>17</label>
<mixed-citation id="jcla23117-cit-0017" publication-type="journal">
<string-name>
<surname>Callaway</surname>
<given-names>JL</given-names>
</string-name>, <string-name>
<surname>Shaffer</surname>
<given-names>LG</given-names>
</string-name>, <string-name>
<surname>Chitty</surname>
<given-names>LS</given-names>
</string-name>, <string-name>
<surname>Rosenfeld</surname>
<given-names>JA</given-names>
</string-name>, <string-name>
<surname>Crolla</surname>
<given-names>JA</given-names>
</string-name>. <article-title>The clinical utility of microarray technologies applied to prenatal cytogenetics in the presence of a normal conventional karyotype: a review of the literature</article-title>. <source xml:lang="en"/>Prenat Diagn. <year>2013</year>;<volume>33</volume>(<issue>12</issue>):<fpage>1119</fpage>‐<lpage>1123</lpage>.<pub-id pub-id-type="pmid">23983223</pub-id></mixed-citation>
</ref>
<ref id="jcla23117-bib-0018">
<label>18</label>
<mixed-citation id="jcla23117-cit-0018" publication-type="journal">
<string-name>
<surname>Armengol</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Nevado</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Serra‐Juhe</surname>
<given-names>C</given-names>
</string-name>, et al. <article-title>Clinical utility of chromosomal microarray analysis in invasive prenatal diagnosis</article-title>. <source xml:lang="en"/>Hum Genet. <year>2012</year>;<volume>131</volume>(<issue>3</issue>):<fpage>513</fpage>‐<lpage>523</lpage>.<pub-id pub-id-type="pmid">21975797</pub-id></mixed-citation>
</ref>
<ref id="jcla23117-bib-0019">
<label>19</label>
<mixed-citation id="jcla23117-cit-0019" publication-type="journal">
<string-name>
<surname>Sagi‐Dain</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Cohen Vig</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Kahana</surname>
<given-names>S</given-names>
</string-name>, et al. <article-title>Chromosomal microarray vs. NIPS: analysis of 5541 low‐risk pregnancies</article-title>. <source xml:lang="en"/>Genet Med. <year>2019</year>;<volume>21</volume>(<issue>11</issue>):<fpage>2462</fpage>‐<lpage>2467</lpage>.<pub-id pub-id-type="pmid">31123319</pub-id></mixed-citation>
</ref>
<ref id="jcla23117-bib-0020">
<label>20</label>
<mixed-citation id="jcla23117-cit-0020" publication-type="journal">
<string-name>
<surname>Van Opstal</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>de Vries</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Govaerts</surname>
<given-names>L</given-names>
</string-name>, et al. <article-title>Benefits and burdens of using a SNP array in pregnancies at increased risk for the common aneuploidies</article-title>. <source xml:lang="en"/>Hum Mutat. <year>2015</year>;<volume>36</volume>(<issue>3</issue>):<fpage>319</fpage>‐<lpage>326</lpage>.<pub-id pub-id-type="pmid">25504762</pub-id></mixed-citation>
</ref>
<ref id="jcla23117-bib-0021">
<label>21</label>
<mixed-citation id="jcla23117-cit-0021" publication-type="journal">
<string-name>
<surname>Cooper</surname>
<given-names>GM</given-names>
</string-name>, <string-name>
<surname>Coe</surname>
<given-names>BP</given-names>
</string-name>, <string-name>
<surname>Girirajan</surname>
<given-names>S</given-names>
</string-name>, et al. <article-title>A copy number variation morbidity map of developmental delay</article-title>. <source xml:lang="en"/>Nat Genet. <year>2011</year>;<volume>43</volume>(<issue>9</issue>):<fpage>838</fpage>‐<lpage>846</lpage>.<pub-id pub-id-type="pmid">21841781</pub-id></mixed-citation>
</ref>
<ref id="jcla23117-bib-0022">
<label>22</label>
<mixed-citation id="jcla23117-cit-0022" publication-type="journal">
<string-name>
<surname>Kaminsky</surname>
<given-names>EB</given-names>
</string-name>, <string-name>
<surname>Kaul</surname>
<given-names>V</given-names>
</string-name>, <string-name>
<surname>Paschall</surname>
<given-names>J</given-names>
</string-name>, et al. <article-title>An evidence‐based approach to establish the functional and clinical significance of copy number variants in intellectual and developmental disabilities</article-title>. <source xml:lang="en"/>Genet Med. <year>2011</year>;<volume>13</volume>(<issue>9</issue>):<fpage>777</fpage>‐<lpage>784</lpage>.<pub-id pub-id-type="pmid">21844811</pub-id></mixed-citation>
</ref>
<ref id="jcla23117-bib-0023">
<label>23</label>
<mixed-citation id="jcla23117-cit-0023" publication-type="journal">
<string-name>
<surname>Srebniak</surname>
<given-names>MI</given-names>
</string-name>, <string-name>
<surname>Diderich</surname>
<given-names>KE</given-names>
</string-name>, <string-name>
<surname>Govaerts</surname>
<given-names>LC</given-names>
</string-name>, et al. <article-title>Types of array findings detectable in cytogenetic diagnosis: a proposal for a generic classification</article-title>. <source xml:lang="en"/>Eur J Hum Genet. <year>2014</year>;<volume>22</volume>(<issue>7</issue>):<fpage>856</fpage>‐<lpage>858</lpage>.<pub-id pub-id-type="pmid">24193341</pub-id></mixed-citation>
</ref>
<ref id="jcla23117-bib-0024">
<label>24</label>
<mixed-citation id="jcla23117-cit-0024" publication-type="journal">
<string-name>
<surname>Girirajan</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Rosenfeld</surname>
<given-names>JA</given-names>
</string-name>, <string-name>
<surname>Cooper</surname>
<given-names>GM</given-names>
</string-name>, et al. <article-title>A recurrent 16p12.1 microdeletion supports a two‐hit model for severe developmental delay</article-title>. <source xml:lang="en"/>Nat Genet. <year>2010</year>;<volume>42</volume>(<issue>3</issue>):<fpage>203</fpage>‐<lpage>209</lpage>.<pub-id pub-id-type="pmid">20154674</pub-id></mixed-citation>
</ref>
<ref id="jcla23117-bib-0025">
<label>25</label>
<mixed-citation id="jcla23117-cit-0025" publication-type="journal">
<string-name>
<surname>Davis</surname>
<given-names>KW</given-names>
</string-name>, <string-name>
<surname>Serrano</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Loddo</surname>
<given-names>S</given-names>
</string-name>, et al. <article-title>Parent‐of‐origin effects in 15q11.2 BP1‐BP2 microdeletion (Burnside‐Butler) syndrome</article-title>. <source xml:lang="en"/>Int J Mol Sci. <year>2019</year>;<volume>20</volume>(<issue>6</issue>):<fpage>1459</fpage>.</mixed-citation>
</ref>
<ref id="jcla23117-bib-0026">
<label>26</label>
<mixed-citation id="jcla23117-cit-0026" publication-type="journal">
<string-name>
<surname>Brabbing‐Goldstein</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Reches</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Svirsky</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Bar‐Shira</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Yaron</surname>
<given-names>Y</given-names>
</string-name>. <article-title>Dilemmas in genetic counseling for low‐penetrance neuro‐susceptibility loci detected on prenatal chromosomal microarray analysis</article-title>. <source xml:lang="en"/>Am J Obstet Gynecol. <year>2018</year>;<volume>218</volume>(<issue>2</issue>):<fpage>247.e1</fpage>‐<lpage>247.e12</lpage>.<pub-id pub-id-type="pmid">29146387</pub-id></mixed-citation>
</ref>
<ref id="jcla23117-bib-0027">
<label>27</label>
<mixed-citation id="jcla23117-cit-0027" publication-type="journal">
<string-name>
<surname>Rosenfeld</surname>
<given-names>JA</given-names>
</string-name>, <string-name>
<surname>Coe</surname>
<given-names>BP</given-names>
</string-name>, <string-name>
<surname>Eichler</surname>
<given-names>EE</given-names>
</string-name>, <string-name>
<surname>Cuckle</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Shaffer</surname>
<given-names>LG</given-names>
</string-name>. <article-title>Estimates of penetrance for recurrent pathogenic copy‐number variations</article-title>. <source xml:lang="en"/>Genet Med. <year>2013</year>;<volume>15</volume>(<issue>6</issue>):<fpage>478</fpage>‐<lpage>481</lpage>.<pub-id pub-id-type="pmid">23258348</pub-id></mixed-citation>
</ref>
<ref id="jcla23117-bib-0028">
<label>28</label>
<mixed-citation id="jcla23117-cit-0028" publication-type="journal">
<string-name>
<surname>Hannes</surname>
<given-names>FD</given-names>
</string-name>, <string-name>
<surname>Sharp</surname>
<given-names>AJ</given-names>
</string-name>, <string-name>
<surname>Mefford</surname>
<given-names>HC</given-names>
</string-name>, et al. <article-title>Recurrent reciprocal deletions and duplications of 16p13.11: the deletion is a risk factor for MR/MCA while the duplication may be a rare benign variant</article-title>. <source xml:lang="en"/>J Med Genet. <year>2009</year>;<volume>46</volume>(<issue>4</issue>):<fpage>223</fpage>‐<lpage>232</lpage>.<pub-id pub-id-type="pmid">18550696</pub-id></mixed-citation>
</ref>
<ref id="jcla23117-bib-0029">
<label>29</label>
<mixed-citation id="jcla23117-cit-0029" publication-type="journal">
<string-name>
<surname>Cox</surname>
<given-names>DM</given-names>
</string-name>, <string-name>
<surname>Butler</surname>
<given-names>MG</given-names>
</string-name>. <article-title>The 15q11.2 BP1‐BP2 microdeletion syndrome: a review</article-title>. <source xml:lang="en"/>Int J Mol Sci. <year>2015</year>;<volume>16</volume>(<issue>2</issue>):<fpage>4068</fpage>‐<lpage>4082</lpage>.<pub-id pub-id-type="pmid">25689425</pub-id></mixed-citation>
</ref>
<ref id="jcla23117-bib-0030">
<label>30</label>
<mixed-citation id="jcla23117-cit-0030" publication-type="journal">
<string-name>
<surname>de Kovel</surname>
<given-names>CG</given-names>
</string-name>, <string-name>
<surname>Trucks</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Helbig</surname>
<given-names>I</given-names>
</string-name>, et al. <article-title>Recurrent microdeletions at 15q11.2 and 16p13.11 predispose to idiopathic generalized epilepsies</article-title>. <source xml:lang="en"/>Brain. <year>2010</year>;<volume>133</volume>(<issue>Pt 1</issue>):<fpage>23</fpage>‐<lpage>32</lpage>.<pub-id pub-id-type="pmid">19843651</pub-id></mixed-citation>
</ref>
<ref id="jcla23117-bib-0031">
<label>31</label>
<mixed-citation id="jcla23117-cit-0031" publication-type="journal">
<string-name>
<surname>Heinzen</surname>
<given-names>EL</given-names>
</string-name>, <string-name>
<surname>Radtke</surname>
<given-names>RA</given-names>
</string-name>, <string-name>
<surname>Urban</surname>
<given-names>TJ</given-names>
</string-name>, et al. <article-title>Rare deletions at 16p13.11 predispose to a diverse spectrum of sporadic epilepsy syndromes</article-title>. <source xml:lang="en"/>Am J Hum Genet. <year>2010</year>;<volume>86</volume>(<issue>5</issue>):<fpage>707</fpage>‐<lpage>718</lpage>.<pub-id pub-id-type="pmid">20398883</pub-id></mixed-citation>
</ref>
<ref id="jcla23117-bib-0032">
<label>32</label>
<mixed-citation id="jcla23117-cit-0032" publication-type="journal">
<string-name>
<surname>Mefford</surname>
<given-names>HC</given-names>
</string-name>, <string-name>
<surname>Muhle</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Ostertag</surname>
<given-names>P</given-names>
</string-name>, et al. <article-title>Genome‐wide copy number variation in epilepsy: novel susceptibility loci in idiopathic generalized and focal epilepsies</article-title>. <source xml:lang="en"/>PLoS Genet. <year>2010</year>;<volume>6</volume>(<issue>5</issue>):<elocation-id>e1000962</elocation-id>.<pub-id pub-id-type="pmid">20502679</pub-id></mixed-citation>
</ref>
<ref id="jcla23117-bib-0033">
<label>33</label>
<mixed-citation id="jcla23117-cit-0033" publication-type="journal">
<string-name>
<surname>Ullmann</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Turner</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Kirchhoff</surname>
<given-names>M</given-names>
</string-name>, et al. <article-title>Array CGH identifies reciprocal 16p13.1 duplications and deletions that predispose to autism and/or mental retardation</article-title>. <source xml:lang="en"/>Hum Mutat. <year>2007</year>;<volume>28</volume>(<issue>7</issue>):<fpage>674</fpage>‐<lpage>682</lpage>.<pub-id pub-id-type="pmid">17480035</pub-id></mixed-citation>
</ref>
<ref id="jcla23117-bib-0034">
<label>34</label>
<mixed-citation id="jcla23117-cit-0034" publication-type="journal">
<string-name>
<surname>Cheng</surname>
<given-names>SSW</given-names>
</string-name>, <string-name>
<surname>Chan</surname>
<given-names>KYK</given-names>
</string-name>, <string-name>
<surname>Leung</surname>
<given-names>KKP</given-names>
</string-name>, et al. <article-title>Experience of chromosomal microarray applied in prenatal and postnatal settings in Hong Kong</article-title>. <source xml:lang="en"/>Am J Med Genet C Semin Med Genet. <year>2019</year>;<volume>181</volume>(<issue>2</issue>):<fpage>196</fpage>‐<lpage>207</lpage>.<pub-id pub-id-type="pmid">30903683</pub-id></mixed-citation>
</ref>
<ref id="jcla23117-bib-0035">
<label>35</label>
<mixed-citation id="jcla23117-cit-0035" publication-type="journal">
<string-name>
<surname>Govaerts</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Srebniak</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Diderich</surname>
<given-names>K</given-names>
</string-name>, et al. <article-title>Prenatal diagnosis of susceptibility loci for neurodevelopmental disorders ‐ genetic counseling and pregnancy outcome in 57 cases</article-title>. <source xml:lang="en"/>Prenat Diagn. <year>2017</year>;<volume>37</volume>(<issue>1</issue>):<fpage>73</fpage>‐<lpage>80</lpage>.<pub-id pub-id-type="pmid">27931090</pub-id></mixed-citation>
</ref>
<ref id="jcla23117-bib-0036">
<label>36</label>
<mixed-citation id="jcla23117-cit-0036" publication-type="journal">
<string-name>
<surname>Hook</surname>
<given-names>EB</given-names>
</string-name>, <string-name>
<surname>Cross</surname>
<given-names>PK</given-names>
</string-name>. <article-title>Extra structurally abnormal chromosomes (ESAC) detected at amniocentesis: frequency in approximately 75,000 prenatal cytogenetic diagnoses and associations with maternal and paternal age</article-title>. <source xml:lang="en"/>Am J Hum Genet. <year>1987</year>;<volume>40</volume>(<issue>2</issue>):<fpage>83</fpage>‐<lpage>101</lpage>.<pub-id pub-id-type="pmid">3471088</pub-id></mixed-citation>
</ref>
<ref id="jcla23117-bib-0037">
<label>37</label>
<mixed-citation id="jcla23117-cit-0037" publication-type="journal">
<string-name>
<surname>Ming</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Shun‐Ping</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Pao‐Lun</surname>
<given-names>Y</given-names>
</string-name>, et al. <article-title>Prenatal identification of small supernumerary marker chromosomes by FISH in an infant born with mild congenital anomalies</article-title>. <source xml:lang="en"/>Prenat Diagn. <year>2010</year>;<volume>26</volume>(<issue>4</issue>):<fpage>383</fpage>‐<lpage>387</lpage>.</mixed-citation>
</ref>
<ref id="jcla23117-bib-0038">
<label>38</label>
<mixed-citation id="jcla23117-cit-0038" publication-type="journal">
<string-name>
<surname>Blennow</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Bui</surname>
<given-names>TH</given-names>
</string-name>, <string-name>
<surname>Kristoffersson</surname>
<given-names>U</given-names>
</string-name>, et al. <article-title>Swedish survey on extra structurally abnormal chromosomes in 39 105 consecutive prenatal diagnoses: prevalence and characterization by fluorescence in situ hybridization</article-title>. <source xml:lang="en"/>Prenat Diagn. <year>2010</year>;<volume>14</volume>(<issue>11</issue>):<fpage>1019</fpage>‐<lpage>1028</lpage>.</mixed-citation>
</ref>
<ref id="jcla23117-bib-0039">
<label>39</label>
<mixed-citation id="jcla23117-cit-0039" publication-type="journal">
<string-name>
<surname>Durham</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Papanna</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Stevens</surname>
<given-names>B</given-names>
</string-name>, et al. <article-title>The utilization of prenatal microarray: a survey of current genetic counseling practices and barriers</article-title>. <source xml:lang="en"/>Prenat Diagn. <year>2019</year>;<volume>39</volume>(<issue>5</issue>):<fpage>351</fpage>‐<lpage>360</lpage>.<pub-id pub-id-type="pmid">30734934</pub-id></mixed-citation>
</ref>
<ref id="jcla23117-bib-0040">
<label>40</label>
<mixed-citation id="jcla23117-cit-0040" publication-type="journal">
<string-name>
<surname>Oneda</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Baldinger</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Reissmann</surname>
<given-names>R</given-names>
</string-name>, et al. <article-title>High‐resolution chromosomal microarrays in prenatal diagnosis significantly increase diagnostic power</article-title>. <source xml:lang="en"/>Prenat Diagn. <year>2014</year>;<volume>34</volume>(<issue>6</issue>):<fpage>525</fpage>‐<lpage>533</lpage>.<pub-id pub-id-type="pmid">24919595</pub-id></mixed-citation>
</ref>
<ref id="jcla23117-bib-0041">
<label>41</label>
<mixed-citation id="jcla23117-cit-0041" publication-type="journal">
<string-name>
<surname>Ganesamoorthy</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Bruno</surname>
<given-names>DL</given-names>
</string-name>, <string-name>
<surname>McGillivray</surname>
<given-names>G</given-names>
</string-name>, et al. <article-title>Meeting the challenge of interpreting high‐resolution single nucleotide polymorphism array data in prenatal diagnosis: does increased diagnostic power outweigh the dilemma of rare variants?</article-title>
<source xml:lang="en"/>BJOG. <year>2013</year>;<volume>120</volume>(<issue>5</issue>):<fpage>594</fpage>‐<lpage>606</lpage>.<pub-id pub-id-type="pmid">23332022</pub-id></mixed-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>